As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps.
With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other.
Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock.
How Glooko integrates with hybrid closed loop systems
Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes.
The hybrid closed loop systems that currently sync with Glooko include:
- mylife Loop (CamAPS FX and Ypsomed)
- Tandem Control-IQ
- Insulet Omnipod 5
- Dana CamAPS® FX
Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems.
|
|
|
Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries).
Benefits of using hybrid closed loop systems with Glooko
There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including:
- Major changes in treatment that reduce daily burdens and mental stress
- More time with glucose levels in range with less effort
- The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates
There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including:
- An increased monitoring of patients with diabetes who are using closed loop systems
- Strengthening their connection with their patients
- Better management of fluctuations in patients’ glucose levels
- Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses
The future of hybrid closed loop systems
Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life.
As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution.
For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.